This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doranz, B. J.
Right arrow Articles by Doms, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doranz, B. J.
Right arrow Articles by Doms, R. W.

 Previous Article  |  Next Article 

Journal of Virology, December 1999, p. 10346-10358, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Use of a gp120 Binding Assay To Dissect the Requirements and Kinetics of Human Immunodeficiency Virus Fusion Events

Benjamin J. Doranz,* Sarah S. W. Baik, and Robert W. Doms*

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104

Received 22 June 1999/Accepted 8 August 1999

Binding of the extracellular subunit of human immunodeficiency type 1 (HIV-1) envelope (Env) glycoprotein (gp120) to CD4 triggers the induction or exposure of a highly conserved coreceptor binding site in gp120 that helps mediate membrane fusion. Characterizing the structural features involved in gp120-coreceptor binding and the conditions under which binding occurs is important for understanding the fusion process, the evolution of pathogenic strains in vivo, the identification of novel anti-HIV compounds, and the development of HIV vaccines that utilize triggered structures of Env. Here we use the kinetics of interaction between CCR5 and gp120 to understand temporal and structural changes that occur during viral fusion. Using saturation binding and homologous competition analysis, we estimated the Kd of interaction between CCR5 and gp120 from the macrophage tropic HIV-1 strain JRFL to be 4 nM. Unlike Env-mediated fusion, gp120 binding to CCR5 did not require divalent cations or elevated temperatures. Binding was not significantly affected by the pH of binding, G-protein coupling of CCR5, or partial gp120 deglycosylation. Oligomeric, uncleaved JRFL gp140 failed to bind CCR5 despite its ability to bind CD4 and monoclonal antibody 17b, suggesting that the uncleaved ectodomain of gp41 interferes with full exposure of the chemokine receptor binding site. Exposure of the chemokine receptor binding site on gp120 could be induced rapidly by CD4, but exposure of this site was lost upon CD4 dissociation from gp120, indicating that the conformational changes in gp120 induced by CD4 binding are fully reversible. The functional gp120-soluble CD4 complex was remarkably stable over time and temperature ranges, offering the possibility that complexes in which the highly conserved coreceptor binding site in gp120 is exposed can be used for vaccine development.

* Corresponding author. Mailing address for Benjamin J. Doranz: University of Pennsylvania, Department of Pathology & Laboratory Medicine, 806 Abramson, 34th and Civic Center Blvd., Philadelphia, PA 19104. Phone: (215) 898-0891. Fax: (215) 573-2883. E-mail: doranz{at}mail.med.upenn.edu. Mailing address for Robert W. Doms: University of Pennsylvania, Department of Pathology & Laboratory Medicine, 807 Abramson, 34th and Civic Center Blvd., Philadelphia, PA 19104. Phone: (215) 898-0890. Fax: (215) 573-2883. E-mail: doms{at}mail.med.upenn.edu.

Journal of Virology, December 1999, p. 10346-10358, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Baker, A.-M., Sauliere, A., Gaibelet, G., Lagane, B., Mazeres, S., Fourage, M., Bachelerie, F., Salome, L., Lopez, A., Dumas, F. (2007). CD4 Interacts Constitutively with Multiple CCR5 at the Plasma Membrane of Living Cells: A FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING AT VARIABLE RADII APPROACH. J. Biol. Chem. 282: 35163-35168 [Abstract] [Full Text]  
  • Heredia, A., Gilliam, B., Latinovic, O., Le, N., Bamba, D., DeVico, A., Melikyan, G. B., Gallo, R. C., Redfield, R. R. (2007). Rapamycin Reduces CCR5 Density Levels on CD4 T Cells, and This Effect Results in Potentiation of Enfuvirtide (T-20) against R5 Strains of Human Immunodeficiency Virus Type 1 In Vitro. Antimicrob. Agents Chemother. 51: 2489-2496 [Abstract] [Full Text]  
  • Melar, M., Ott, D. E., Hope, T. J. (2007). Physiological Levels of Virion-Associated Human Immunodeficiency Virus Type 1 Envelope Induce Coreceptor-Dependent Calcium Flux. J. Virol. 81: 1773-1785 [Abstract] [Full Text]  
  • Gaibelet, G., Planchenault, T., Mazeres, S., Dumas, F., Arenzana-Seisdedos, F., Lopez, A., Lagane, B., Bachelerie, F. (2006). CD4 and CCR5 Constitutively Interact at the Plasma Membrane of Living Cells: A CONFOCAL FLUORESCENCE RESONANCE ENERGY TRANSFER-BASED APPROACH. J. Biol. Chem. 281: 37921-37929 [Abstract] [Full Text]  
  • Mkrtchyan, S. R., Markosyan, R. M., Eadon, M. T., Moore, J. P., Melikyan, G. B., Cohen, F. S. (2005). Ternary Complex Formation of Human Immunodeficiency Virus Type 1 Env, CD4, and Chemokine Receptor Captured as an Intermediate of Membrane Fusion. J. Virol. 79: 11161-11169 [Abstract] [Full Text]  
  • Heap, C. J., Reading, S. A., Dimmock, N. J. (2005). An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus-cell fusion. J. Gen. Virol. 86: 1499-1507 [Abstract] [Full Text]  
  • Karlsson, I., Antonsson, L., Shi, Y., Oberg, M., Karlsson, A., Albert, J., Olde, B., Owman, C., Jansson, M., Fenyo, E. M. (2004). Coevolution of RANTES Sensitivity and Mode of CCR5 Receptor Use by Human Immunodeficiency Virus Type 1 of the R5 Phenotype. J. Virol. 78: 11807-11815 [Abstract] [Full Text]  
  • Yuan, W., Craig, S., Si, Z., Farzan, M., Sodroski, J. (2004). CD4-Induced T-20 Binding to Human Immunodeficiency Virus Type 1 gp120 Blocks Interaction with the CXCR4 Coreceptor. J. Virol. 78: 5448-5457 [Abstract] [Full Text]  
  • Reeves, J. D., Miamidian, J. L., Biscone, M. J., Lee, F.-H., Ahmad, N., Pierson, T. C., Doms, R. W. (2004). Impact of Mutations in the Coreceptor Binding Site on Human Immunodeficiency Virus Type 1 Fusion, Infection, and Entry Inhibitor Sensitivity. J. Virol. 78: 5476-5485 [Abstract] [Full Text]  
  • Center, R. J., Lebowitz, J., Leapman, R. D., Moss, B. (2004). Promoting Trimerization of Soluble Human Immunodeficiency Virus Type 1 (HIV-1) Env through the Use of HIV-1/Simian Immunodeficiency Virus Chimeras. J. Virol. 78: 2265-2276 [Abstract] [Full Text]  
  • Golding, H., Aliberti, J., King, L. R., Manischewitz, J., Andersen, J., Valenzuela, J., Landau, N. R., Sher, A. (2003). Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii. Blood 102: 3280-3286 [Abstract] [Full Text]  
  • Kuwasaki, T., Hatta, M., Takeuchi, H., Takaku, H. (2003). Inhibition of human immunodeficiency virus 1 replication in vitro by a self-stabilized oligonucleotide with 2'-O-methyl-guanosine-uridine quadruplex motifs. J Antimicrob Chemother 51: 813-819 [Abstract] [Full Text]  
  • Suphaphiphat, P., Thitithanyanont, A., Paca-Uccaralertkun, S., Essex, M., Lee, T.-H. (2003). Effect of Amino Acid Substitution of the V3 and Bridging Sheet Residues in Human Immunodeficiency Virus Type 1 Subtype C gp120 on CCR5 Utilization. J. Virol. 77: 3832-3837 [Abstract] [Full Text]  
  • Lin, G., Baribaud, F., Romano, J., Doms, R. W., Hoxie, J. A. (2002). Identification of gp120 Binding Sites on CXCR4 by Using CD4-Independent Human Immunodeficiency Virus Type 2 Env Proteins. J. Virol. 77: 931-942 [Abstract] [Full Text]  
  • Lin, G., Simmons, G., Pohlmann, S., Baribaud, F., Ni, H., Leslie, G. J., Haggarty, B. S., Bates, P., Weissman, D., Hoxie, J. A., Doms, R. W. (2002). Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR. J. Virol. 77: 1337-1346 [Abstract] [Full Text]  
  • Reeves, J. D., Gallo, S. A., Ahmad, N., Miamidian, J. L., Harvey, P. E., Sharron, M., Pohlmann, S., Sfakianos, J. N., Derdeyn, C. A., Blumenthal, R., Hunter, E., Doms, R. W. (2002). Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics. Proc. Natl. Acad. Sci. USA 99: 16249-16254 [Abstract] [Full Text]  
  • Viard, M., Parolini, I., Sargiacomo, M., Fecchi, K., Ramoni, C., Ablan, S., Ruscetti, F. W., Wang, J. M., Blumenthal, R. (2002). Role of Cholesterol in Human Immunodeficiency Virus Type 1 Envelope Protein-Mediated Fusion with Host Cells. J. Virol. 76: 11584-11595 [Abstract] [Full Text]  
  • Giannecchini, S., Isola, P., Sichi, O., Matteucci, D., Pistello, M., Zaccaro, L., Del Mauro, D., Bendinelli, M. (2002). AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Failure To Protect and Possible Enhancement of Challenge Infection by Four Cell-Based Vaccines Prepared with Autologous Lymphoblasts. J. Virol. 76: 6882-6892 [Abstract] [Full Text]  
  • Lewicki, D. N., Gallagher, T. M. (2002). Quaternary Structure of Coronavirus Spikes in Complex with Carcinoembryonic Antigen-related Cell Adhesion Molecule Cellular Receptors. J. Biol. Chem. 277: 19727-19734 [Abstract] [Full Text]  
  • Arthos, J., Cicala, C., Steenbeke, T. D., Chun, T.-W., Cruz, C. D., Hanback, D. B., Khazanie, P., Nam, D., Schuck, P., Selig, S. M., Van Ryk, D., Chaikin, M. A., Fauci, A. S. (2002). Biochemical and Biological Characterization of a Dodecameric CD4-Ig Fusion Protein. IMPLICATIONS FOR THERAPEUTIC AND VACCINE STRATEGIES. J. Biol. Chem. 277: 11456-11464 [Abstract] [Full Text]  
  • Papandreou, M.-J., Barbouche, R., Guieu, R., Kieny, M. P., Fenouillet, E. (2002). The alpha -Glucosidase Inhibitor 1-Deoxynojirimycin Blocks Human Immunodeficiency Virus Envelope Glycoprotein-Mediated Membrane Fusion at the CXCR4 Binding Step. Mol. Pharmacol. 61: 186-193 [Abstract] [Full Text]  
  • Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Zhang, Z., O'Brien, W. A., Ratner, L., Shaw, G. M., Hunter, E. (2001). Sensitivity of Human Immunodeficiency Virus Type 1 to Fusion Inhibitors Targeted to the gp41 First Heptad Repeat Involves Distinct Regions of gp41 and Is Consistently Modulated by gp120 Interactions with the Coreceptor. J. Virol. 75: 8605-8614 [Abstract] [Full Text]  
  • Singer, I. I., Scott, S., Kawka, D. W., Chin, J., Daugherty, B. L., DeMartino, J. A., DiSalvo, J., Gould, S. L., Lineberger, J. E., Malkowitz, L., Miller, M. D., Mitnaul, L., Siciliano, S. J., Staruch, M. J., Williams, H. R., Zweerink, H. J., Springer, M. S. (2001). CCR5, CXCR4, and CD4 Are Clustered and Closely Apposed on Microvilli of Human Macrophages and T Cells. J. Virol. 75: 3779-3790 [Abstract] [Full Text]  
  • York, J., Follis, K. E., Trahey, M., Nyambi, P. N., Zolla-Pazner, S., Nunberg, J. H. (2001). Antibody Binding and Neutralization of Primary and T-Cell Line-Adapted Isolates of Human Immunodeficiency Virus Type 1. J. Virol. 75: 2741-2752 [Abstract] [Full Text]  
  • Spenlehauer, C., Kirn, A., Aubertin, A.-M., Moog, C. (2001). Antibody-Mediated Neutralization of Primary Human Immunodeficiency Virus Type 1 Isolates: Investigation of the Mechanism of Inhibition. J. Virol. 75: 2235-2245 [Abstract] [Full Text]  
  • Doms, R. W., Trono, D. (2000). The plasma membrane as a combat zone in the HIV battlefield. Genes Dev. 14: 2677-2688 [Full Text]  
  • Melikyan, G. B., Markosyan, R. M., Hemmati, H., Delmedico, M. K., Lambert, D. M., Cohen, F. S. (2000). Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion. JCB 151: 413-424 [Abstract] [Full Text]  
  • Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., Kappes, J. C., Shaw, G. M., Hunter, E. (2000). Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of gp120. J. Virol. 74: 8358-8367 [Abstract] [Full Text]  
  • Kowalska, M. A., Ratajczak, M. Z., Majka, M., Jin, J., Kunapuli, S., Brass, L., Poncz, M. (2000). Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets. Blood 96: 50-57 [Abstract] [Full Text]  
  • Lee, S., Lapham, C. K., Chen, H., King, L., Manischewitz, J., Romantseva, T., Mostowski, H., Stantchev, T. S., Broder, C. C., Golding, H. (2000). Coreceptor Competition for Association with CD4 May Change the Susceptibility of Human Cells to Infection with T-Tropic and Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1. J. Virol. 74: 5016-5023 [Abstract] [Full Text]  
  • Kliger, Y., Gallo, S. A., Peisajovich, S. G., Munoz-Barroso, I., Avkin, S., Blumenthal, R., Shai, Y. (2001). Mode of Action of an Antiviral Peptide from HIV-1. INHIBITION AT A POST-LIPID MIXING STAGE. J. Biol. Chem. 276: 1391-1397 [Abstract] [Full Text]  
  • Hoffman, T. L., Canziani, G., Jia, L., Rucker, J., Doms, R. W. (2000). A biosensor assay for studying ligand-membrane receptor interactions: Binding of antibodies and HIV-1 Env to chemokine receptors. Proc. Natl. Acad. Sci. USA 97: 11215-11220 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»